We estimate that there will be 13· 7 million new cases of childhood cancer globally between
2020 and 2050. At current levels of health system performance (including access and …

We performed a literature review to examine barriers for rhabdomyosarcoma treatment in
low‐resource settings, and identified 29 articles from 14 middle‐income countries, with none …

Multiple resource-related and infrastructure-related challenges contribute to poorer
outcomes, and these require systematic, multidisciplinary, and structured solutions …

Rhabdomyosarcoma is one of the most common soft-tissue sarcomas in children. The
therapy for this condition has evolved significantly over recent decades, as has survival …

Background: Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in
children. Anaplasia is a rare phenomenon seen in childhood RMS. The most common …

Rhabdomyosarcoma is an aggressive malignant striated muscle neoplasm commonly seen
in children involving orbit, paranasal sinuses, cheek, tongue, and rarely upper lip. The …

Objective: To evaluate the clinical characteristics and treatment outcomes of children with
rhabdomyosarcoma diagnosed and treated at King Hussein Medical Center. Methods: This …